Alkermes Statistics
Total Valuation
Alkermes has a market cap or net worth of $5.79 billion. The enterprise value is $5.27 billion.
| Market Cap | 5.79B |
| Enterprise Value | 5.27B |
Important Dates
The next estimated earnings date is Thursday, April 30, 2026, before market open.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Alkermes has 166.25 million shares outstanding. The number of shares has decreased by -0.27% in one year.
| Current Share Class | 166.25M |
| Shares Outstanding | 166.25M |
| Shares Change (YoY) | -0.27% |
| Shares Change (QoQ) | +0.61% |
| Owned by Insiders (%) | 1.50% |
| Owned by Institutions (%) | 104.45% |
| Float | 153.68M |
Valuation Ratios
The trailing PE ratio is 24.36 and the forward PE ratio is 17.61.
| PE Ratio | 24.36 |
| Forward PE | 17.61 |
| PS Ratio | 3.92 |
| Forward PS | 3.16 |
| PB Ratio | 3.17 |
| P/TBV Ratio | 3.34 |
| P/FCF Ratio | 12.06 |
| P/OCF Ratio | 11.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.76, with an EV/FCF ratio of 10.98.
| EV / Earnings | 21.82 |
| EV / Sales | 3.57 |
| EV / EBITDA | 18.76 |
| EV / EBIT | 20.77 |
| EV / FCF | 10.98 |
Financial Position
The company has a current ratio of 3.55, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.55 |
| Quick Ratio | 1.70 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.24 |
| Debt / FCF | 0.15 |
| Interest Coverage | 20.69 |
Financial Efficiency
Return on equity (ROE) is 14.72% and return on invested capital (ROIC) is 21.11%.
| Return on Equity (ROE) | 14.72% |
| Return on Assets (ROA) | 6.99% |
| Return on Invested Capital (ROIC) | 21.11% |
| Return on Capital Employed (ROCE) | 13.07% |
| Weighted Average Cost of Capital (WACC) | 6.50% |
| Revenue Per Employee | $719,951 |
| Profits Per Employee | $117,885 |
| Employee Count | 2,050 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.04 |
Taxes
In the past 12 months, Alkermes has paid $49.79 million in taxes.
| Income Tax | 49.79M |
| Effective Tax Rate | 17.08% |
Stock Price Statistics
The stock price has increased by +7.10% in the last 52 weeks. The beta is 0.39, so Alkermes's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | +7.10% |
| 50-Day Moving Average | 31.42 |
| 200-Day Moving Average | 29.73 |
| Relative Strength Index (RSI) | 70.71 |
| Average Volume (20 Days) | 3,001,861 |
Short Selling Information
The latest short interest is 20.60 million, so 12.39% of the outstanding shares have been sold short.
| Short Interest | 20.60M |
| Short Previous Month | 18.20M |
| Short % of Shares Out | 12.39% |
| Short % of Float | 13.41% |
| Short Ratio (days to cover) | 9.99 |
Income Statement
In the last 12 months, Alkermes had revenue of $1.48 billion and earned $241.66 million in profits. Earnings per share was $1.43.
| Revenue | 1.48B |
| Gross Profit | 1.28B |
| Operating Income | 253.96M |
| Pretax Income | 291.45M |
| Net Income | 241.66M |
| EBITDA | 281.12M |
| EBIT | 253.96M |
| Earnings Per Share (EPS) | $1.43 |
Balance Sheet
The company has $588.22 million in cash and $70.00 million in debt, with a net cash position of $518.22 million or $3.12 per share.
| Cash & Cash Equivalents | 588.22M |
| Total Debt | 70.00M |
| Net Cash | 518.22M |
| Net Cash Per Share | $3.12 |
| Equity (Book Value) | 1.82B |
| Book Value Per Share | 10.99 |
| Working Capital | 1.39B |
Cash Flow
In the last 12 months, operating cash flow was $520.75 million and capital expenditures -$40.42 million, giving a free cash flow of $480.33 million.
| Operating Cash Flow | 520.75M |
| Capital Expenditures | -40.42M |
| Depreciation & Amortization | 27.17M |
| Net Borrowing | n/a |
| Free Cash Flow | 480.33M |
| FCF Per Share | $2.89 |
Margins
Gross margin is 86.69%, with operating and profit margins of 17.21% and 16.37%.
| Gross Margin | 86.69% |
| Operating Margin | 17.21% |
| Pretax Margin | 19.75% |
| Profit Margin | 16.37% |
| EBITDA Margin | 19.05% |
| EBIT Margin | 17.21% |
| FCF Margin | 32.55% |
Dividends & Yields
Alkermes does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.27% |
| Shareholder Yield | n/a |
| Earnings Yield | 4.17% |
| FCF Yield | 8.29% |
Analyst Forecast
The average price target for Alkermes is $43.29, which is 24.25% higher than the current price. The consensus rating is "Buy".
| Price Target | $43.29 |
| Price Target Difference | 24.25% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 11.54% |
| EPS Growth Forecast (5Y) | 36.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 15, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | May 15, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Alkermes has an Altman Z-Score of 5.63 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.63 |
| Piotroski F-Score | 6 |